Associated Papers
Genomic Analysis of Tumors from Patients with Glioblastoma with Long-Term Response to Afatinib.
Owen S et al.
Oncotargets and Therapy, 2022
Genomic Profiling Identified Novel Prognostic Biomarkers in Chinese Midline Glioma Patients.
Li H et al.
Frontiers in Oncology, 2020
33747896 (PubMed )
Supplement: Table_1.xlsx › Table_S2
Afatinib, an irreversible ErbB family blocker, with protracted temozolomide in recurrent glioblastoma: a case report.
Alshami J et al.
Oncotarget, 2015
Select a paper to view details